Stages of hair fall Medications and treatment procedure

Reading File
Finding Sources
Finding Sources
Searching PubMed

androgenetic alopecia treatment

Searching the Web

stages of hair loss Hamilton Norwood scale androgenetic alopecia treatment 2025

Reading File
Reading File
Reading File
I now have comprehensive information from the textbooks and web sources to write a thorough answer. Let me compile this.

Stages of Hair Loss & Treatment

Understanding the Hair Loss Cycle

Hair loss (alopecia) occurs when the normal hair cycle - anagen (growth), catagen (transition), telogen (rest) - is disrupted. In androgenetic alopecia (AGA), the most common type, DHT (dihydrotestosterone) progressively miniaturizes terminal pigmented hairs into fine, hypopigmented vellus hairs. Stem cells in the follicle bulge are preserved in bald scalp, but progenitor cells are markedly reduced, which is why follicles stop producing hair shafts.

Stages of Hair Loss

Males - Hamilton-Norwood Scale (7 Stages)

Developed by Hamilton (1951) and revised by Norwood (1975), this is the global standard for grading male pattern baldness.
StageDescriptionKey Feature
Stage 1No clinically significant hair lossHairline at original position - baseline
Stage 2Slight bilateral recession at temples"M"-shaped mature hairline; symmetrical
Stage 3Deep recession at temples, pronounced "M" or "U" shapeFirst stage considered clinically significant hair loss
Stage 3 VertexSignificant loss at the crown (vertex) with relatively spared frontal lineCrown bald patch appears
Stage 4More pronounced temple recession + thinning at crown, separated by a band of hairTwo distinct balding zones
Stage 5The two bald areas enlarge; the separating band thinsBand of hair still present but narrow
Stage 6Temple and crown zones merge completely"Monk's baldness" - continuous bald area across top
Stage 7Most advanced stage - only a narrow horseshoe band of hair remains at sides and backEntire top of head bald
Type A variants (Stages 2A-5A): Hair recedes uniformly front-to-back, without a distinct vertex bald spot forming separately.

Females - Ludwig Scale (3 Grades)

Female pattern hair loss is diffuse thinning over the crown, unlike the distinct zones in men. The Ludwig scale grades severity:
GradeDescription
Grade IThinning noticeable on the crown, part line widens; frontal hairline preserved
Grade IISignificant diffuse thinning over the crown with wider part
Grade IIINearly complete baldness over crown; frontal hairline still maintained
The Sinclair scale is also used, rating females on a 1-5 scale with Grade 1 = normal parting width and Grade 5 = diffuse thinning similar to male pattern.

Pathogenesis

  • DHT-driven miniaturization: 5α-reductase converts testosterone to DHT, which binds androgen receptors in hair follicles and shortens anagen (growth) phase progressively
  • Genetics: Polygenic inheritance; androgen receptor gene (AR) on the X chromosome (Xq11-12) is the major determinant in men. The AR-CAG repeat polymorphism inversely correlates with androgen sensitivity
  • Prostaglandin D2 (PGD2): Elevated in bald scalp; inhibits hair growth via its receptors (a therapeutic target under investigation)
  • Wnt/β-catenin signaling: Recent 2025 research identified suppression of this pathway as an additional mechanism in follicular miniaturization

Medical Treatment

1. Minoxidil (Topical & Oral)

  • Topical: 5% solution/foam in men; 2% in women (FDA-approved). Applied once or twice daily to the scalp
  • Oral low-dose minoxidil: 0.25-2.5 mg/day - effective and generally well-tolerated (Goldman-Cecil Medicine)
  • Mechanism: Vasodilator that prolongs anagen phase and increases follicle size
  • Key point: Stopping minoxidil causes an acute telogen efflux 3-4 months later (hair shed accelerates). Regular use is mandatory to maintain results.

2. Finasteride (Oral)

  • Dose: 1 mg/day orally (FDA-approved for men only)
  • Mechanism: Inhibits 5α-reductase, reducing conversion of testosterone to DHT
  • Effect: Slows progression and promotes regrowth - improvement mostly seen as thickening of existing hairs
  • Caution: Post-finasteride syndrome - persistent sexual dysfunction and depression reported in some men after stopping
  • Stopping finasteride leads to gradual return of hair loss, reaching pretreatment status within ~1 year

3. Finasteride Topical Spray

  • As effective as oral finasteride but with less systemic impact on DHT levels - preferred where systemic side effects are a concern

4. Dutasteride (Oral)

  • Dose: 0.5 mg/day (approved in some countries, e.g., Japan, South Korea)
  • Inhibits both type 1 and type 2 5α-reductase (vs. finasteride which inhibits only type 2)
  • More effective than finasteride with a comparable safety profile

5. Spironolactone / Anti-androgens (Women)

  • Spironolactone (100-200 mg/day) and cyproterone acetate used in women to block androgen receptors
  • Not appropriate for men due to feminizing side effects

General Treatment Notes

  • All medical treatments should be continued for at least 6 months before assessing efficacy
  • A 2025 network meta-analysis confirmed that the combination of finasteride + minoxidil is the most effective medical regimen for AGA in men
  • Early intervention (Stages 1-2) yields the best outcomes - preserving existing hair is easier than restoring lost hair

Non-Pharmacological Treatments

Platelet-Rich Plasma (PRP)

  • Injections of concentrated autologous growth factors into the scalp
  • Stimulates follicle activity and prolongs anagen
  • A typical protocol: 3 monthly injections + 1 booster at 3 months
  • Evidence is mixed - one RCT found PRP vs. saline gave similar results; more standardization of protocols is needed
  • Used adjunctively with minoxidil/finasteride for better outcomes

Low-Level Laser Therapy (LLLT) / Photobiomodulation

  • FDA-cleared devices (laser combs, helmets, caps)
  • Stimulates mitochondrial activity in hair follicles and extends anagen phase
  • A 2025 evidence-based consensus in JAAD supports its use as an adjunct therapy
  • Best suited for Norwood Stages 2-4

Surgical Treatment: Hair Transplantation

Hair transplantation is based on donor dominance - terminal hairs from the unaffected posterior/occipital scalp maintain their growth pattern even after transplantation to balding areas.

Techniques

TechniqueHow it Works
FUT (Follicular Unit Transplantation / Strip)A strip of scalp is excised from the donor area; individual follicular units are dissected and transplanted
FUE (Follicular Unit Extraction)Individual follicular units (1-4 hairs each) are extracted one by one using a punch device and transplanted
  • Modern transplants use individual follicular units (1-4 hairs per graft), producing a natural appearance - a revolution from the older "plug" method
  • Post-transplant, patients are encouraged to continue topical/oral minoxidil and finasteride to slow ongoing miniaturization and maximize the perceived density

Candidate Criteria

  • Suitable for men with Norwood Stages 3-7 with adequate donor hair density
  • Female transplantation is more complex - diffuse thinning in the parietal/occipital region means the donor area may also be affected
  • Young patients (Stage 3) should consider 12-18 months of medical therapy first to assess the final pattern before committing to surgery

Treatment by Stage (Summary)

StageRecommended Approach
1-2Preventive: lifestyle optimization, early minoxidil or finasteride
3-3VMinoxidil + finasteride; consider PRP or LLLT as adjuncts
4-5Combination medical therapy; hair transplant if progressing
6-7Hair transplant (FUE/FUT) is primary option; medical therapy to protect remaining hair

Alopecia Areata (Patchy Hair Loss) - Brief Note

This is a distinct autoimmune, non-scarring form affecting up to 2% of the population. Triggered by a CD8+ T-cell attack on hair follicles via the JAK/STAT pathway. Treatment now includes JAK inhibitors - ritlecitinib and baricitinib are approved (a 2025 systematic review confirmed ritlecitinib vs. baricitinib efficacy). Severe forms: alopecia totalis (entire scalp) or alopecia universalis (all body hair).

Sources: Dermatology 2-Volume Set 5e (Elsevier), Goldman-Cecil Medicine (International Edition), Andrews' Diseases of the Skin; supplemented by PubMed 2024-2025 systematic reviews and the Hamilton-Norwood classification.
This is a shared conversation. Sign in to Orris to start your own chat.